TP53 and diffuse large B-cell lymphoma: Since these studies suggest that genetic- and epigenetic disruption of the p53-miR34A-DAPK network may be associated with worse outcome in DLBCL patients, we speculated whether this pathway was also disrupted in CNS DLBCL.